Human Positive Coactivator 4 Affects the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma via the mTOR/P70s6k Signaling Pathway

INTRODUCTION: Pancreatic cancer is one of the deadliest cancers in the world, and pancreatic ductal adenocarcinoma (PDAC) accounts for 90% of all cases. Human positive coactivator 4 (PC4) is a transcriptional coactivator that has been associated with the development and progression of several tumors...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Xingxing, Yang, Yishi, Ma, Le, Luo, Peng, Shen, Kaicheng, Dai, Haisu, Jiang, Yan, Shuai, Ling, Liu, Zhipeng, You, Jinshan, Min, Ke, Shi, Chunmeng, Chen, Zhiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705283/
https://www.ncbi.nlm.nih.gov/pubmed/33273827
http://dx.doi.org/10.2147/OTT.S284219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705283/
https://www.ncbi.nlm.nih.gov/pubmed/33273827
http://dx.doi.org/10.2147/OTT.S284219

Ejemplares similares